Evidence map›Paper›PMID 30891621›Full record

ReviewCellular and molecular life sciences : CMLS2019

Extracellular vesicle isolation methods: rising impact of size-exclusion chromatography.

Marta Monguió-Tortajada, Carolina Gálvez-Montón, Antoni Bayes-Genis, Santiago Roura, Francesc E Borràs

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 264 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
264citing papers in PubMed, 2 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

264 citing papers in PubMed, 2 syntheses or guidelines pooled it, 421 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Natural Product-Derived Vesicles in Nanotherapeutics.Journal of extracellular vesicles · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

204 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marta Monguió-TortajadaREMAR-IVECAT Group, Germans Trias i Pujol Health Science Research Institute, Can Ruti Campus, Badalona, Spain.
Carolina Gálvez-MontónICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Can Ruti Campus, Badalona, Spain.
Antoni Bayes-GenisICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Can Ruti Campus, Badalona, Spain.
Santiago RouraICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Can Ruti Campus, Badalona, Spain. sroura@igtp.cat.ORCID http://orcid.org/0000-0003-4063-9661
Francesc E BorràsREMAR-IVECAT Group, Germans Trias i Pujol Health Science Research Institute, Can Ruti Campus, Badalona, Spain. feborras@igtp.cat.ORCID http://orcid.org/0000-0003-4038-1912
Instituto de Salud Carlos III · ESUniversitat Autònoma de Barcelona · ES

Funding

Fundació la Marató de TV3 201502-30Fundació la Marató de TV3 201516-10Generalitat de Catalunya 2017-SGR-301Generalitat de Catalunya 2017-SGR-483Generalitat de Catalunya (ES) SLT002/16/00234 PERISInstituto de Salud Carlos III CB16/11/00403 CIBER CardiovascularInstituto de Salud Carlos III PI17/00336Instituto de Salud Carlos III PI17/01487Instituto de Salud Carlos III PIC18/00014Instituto de Salud Carlos III RD16/0009 Feder FundsInstituto de Salud Carlos III RD16/00111/0006 TerCelMinisterio de Economía, Industria y Competitividad, Gobierno de España SAF2017-84324-C2-1-R
6 · The paper itself

Abstract

Extracellular vesicles (EVs) include a variety of nanosized vesicles released to the extracellular microenvironment by the vast majority of cells transferring bioactive lipids, proteins, mRNA, miRNA or non-coding RNA, as means of intercellular communication. Remarkably, among other fields of research, their use has become promising for immunomodulation, tissue repair and as source for novel disease-specific molecular signatures or biomarkers. However, a major challenge is to define accurate, reliable and easily implemented techniques for EV isolation due to their nanoscale size and high heterogeneity. In this context, differential ultracentrifugation (dUC) has been the most widely used laboratory methodology, but alternative procedures have emerged to allow purer EV preparations with easy implementation. Here, we present and discuss the most used of the different EV isolation methods, focusing on the increasing impact of size exclusion chromatography (SEC) on the resulting EV preparations from in vitro cultured cells-conditioned medium and biological fluids. Comparatively, low protein content and cryo-electron microscopy analysis show that SEC removes most of the overabundant soluble plasma proteins, which are not discarded using dUC or precipitating agents, while being more user friendly and less time-consuming than gradient-based EV isolation. Also, SEC highly maintains the major EVs' characteristics, including vesicular structure and content, which guarantee forthcoming applications. In sum, together with scaling-up possibilities to increase EV recovery and manufacturing following high-quality standards, SEC could be easily adapted to most laboratories to assist EV-associated biomarker discovery and to deliver innovative cell-free immunomodulatory and pro-regenerative therapies.

Indexed as

AnimalsChemical PrecipitationChromatography, GelExtracellular VesiclesFlow CytometryHumansLab-On-A-Chip DevicesUltracentrifugationUltrafiltrationExosomesIsolation methodsNanomedicinePurificationTheranostics

Identifiers

PMID30891621
PMCPMC11105396
OpenAlexW2938866342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.